Dr. Mark Devore, MD

NPI: 1578521217
Total Payments
$24,377
2024 Payments
$3,338
Companies
55
Transactions
1,266
Medicare Patients
4,975
Medicare Billing
$604,573

Payment Breakdown by Category

Food & Beverage$24,091 (98.8%)
Education$251.66 (1.0%)
Gifts$34.46 (0.1%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $24,091 1,257 98.8%
Education $251.66 8 1.0%
Gift $34.46 1 0.1%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $6,987 327 $0 (2024)
Janssen Biotech, Inc. $4,383 273 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $2,082 134 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,304 70 $0 (2024)
Gilead Sciences, Inc. $1,265 45 $0 (2024)
Celgene Corporation $1,123 71 $0 (2024)
Janssen Scientific Affairs, LLC $657.72 7 $0 (2024)
Merck Sharp & Dohme LLC $566.78 35 $0 (2022)
GENZYME CORPORATION $438.88 7 $0 (2024)
IRONWOOD PHARMACEUTICALS, INC $437.35 24 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,338 135 ABBVIE INC. ($919.67)
2023 $4,045 175 AbbVie Inc. ($1,130)
2022 $3,703 192 ABBVIE INC. ($1,347)
2021 $2,842 145 Janssen Biotech, Inc. ($760.37)
2020 $1,461 79 AbbVie Inc. ($478.70)
2019 $3,014 166 AbbVie, Inc. ($922.72)
2018 $3,480 211 AbbVie, Inc. ($843.71)
2017 $2,495 163 AbbVie, Inc. ($683.54)

All Payment Transactions

1,266 individual payment records from CMS Open Payments — Page 1 of 51

Date Company Product Nature Form Amount Type
12/18/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $21.07 General
Category: Gastroenterology
12/18/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $19.61 General
Category: Gastroenterology
12/18/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $16.02 General
Category: GI
12/17/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $15.09 General
Category: GASTROENTEROLOGY
12/16/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $24.08 General
Category: INTERNAL MEDICINE
12/11/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $40.53 General
Category: INTERNAL MEDICINE
12/06/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $12.72 General
Category: Immunology
12/05/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $18.07 General
Category: GASTROENTEROLOGY
12/03/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $19.48 General
Category: INTERNAL MEDICINE
11/27/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $21.41 General
Category: Immunology
11/22/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $21.18 General
Category: THERAPY FOR CSID
11/20/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $20.93 General
Category: Immunology
11/19/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $25.72 General
Category: IMMUNOLOGY
11/15/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $25.46 General
Category: IMMUNOLOGY
11/13/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $20.81 General
Category: Immunology
11/13/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $19.89 General
Category: Gastroenterology
11/13/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $16.11 General
Category: GASTROENTEROLOGY
11/11/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $20.98 General
Category: INTERNAL MEDICINE
11/06/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $31.87 General
Category: INTERNAL MEDICINE
11/06/2024 Lilly USA, LLC OMVOH (Drug), ZEPBOUND Food and Beverage In-kind items and services $24.02 General
Category: Immunology
11/01/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $16.70 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
10/28/2024 Sandoz Inc. HYRIMOZ (Biological) Food and Beverage In-kind items and services $22.65 General
Category: Immunology
10/24/2024 Regeneron Healthcare Solutions, Inc. Food and Beverage In-kind items and services $107.10 General
10/23/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $31.22 General
Category: IMMUNOLOGY
10/23/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $20.37 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 17 1,334 1,668 $567,060 $158,130
2022 14 1,156 1,352 $469,570 $144,501
2021 14 1,307 1,505 $580,130 $165,331
2020 15 1,178 1,347 $441,015 $136,611
Total Patients
4,975
Total Services
5,872
Medicare Billing
$604,573
Procedure Codes
61

All Medicare Procedures & Services

61 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2023 174 174 $130,500 $32,747 25.1%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 147 154 $42,350 $21,435 50.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 198 229 $40,075 $21,218 52.9%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 153 300 $29,730 $18,869 63.5%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 158 166 $103,900 $11,892 11.4%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 96 97 $72,750 $11,124 15.3%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 41 42 $35,700 $7,323 20.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 87 93 $11,160 $6,193 55.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 39 39 $8,775 $4,601 52.4%
88305 Pathology examination of tissue using a microscope, intermediate complexity Office 2023 74 160 $28,800 $4,369 15.2%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 38 38 $7,600 $3,472 45.7%
88313 Special stained specimen slides to examine tissue including interpretation and report Office 2023 26 59 $10,620 $3,268 30.8%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 16 16 $11,200 $3,038 27.1%
88312 Special stained specimen slides to identify organisms including interpretation and report Office 2023 26 31 $5,580 $2,118 38.0%
43248 Insertion of guide wire with dilation of esophagus using a flexible endoscope Facility 2023 19 19 $13,300 $2,093 15.7%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 19 19 $3,800 $2,018 53.1%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 11 13 $7,800 $1,902 24.4%
88305 Pathology examination of tissue using a microscope, intermediate complexity Facility 2023 12 19 $3,420 $450.41 13.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 206 242 $42,350 $23,438 55.3%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 135 142 $39,050 $22,936 58.7%
G0105 Colorectal cancer screening; colonoscopy on individual at high risk Facility 2022 99 99 $74,250 $19,250 25.9%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 161 298 $26,820 $17,473 65.2%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 114 114 $85,500 $14,670 17.2%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 142 150 $82,500 $10,941 13.3%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 49 49 $41,650 $7,575 18.2%

About Dr. Mark Devore, MD

Dr. Mark Devore, MD is a Gastroenterology healthcare provider based in Southfield, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578521217.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Devore, MD has received a total of $24,377 in payments from pharmaceutical and medical device companies, with $3,338 received in 2024. These payments were reported across 1,266 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($24,091).

As a Medicare-enrolled provider, Devore has provided services to 4,975 Medicare beneficiaries, totaling 5,872 services with total Medicare billing of $604,573. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Southfield, MI
  • Active Since 05/03/2006
  • Last Updated 05/11/2021
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1578521217

Products in Payments

  • STELARA (Biological) $4,431
  • ZEPOSIA (Drug) $1,480
  • RINVOQ (Biological) $1,383
  • Humira (Biological) $1,204
  • XIFAXAN (Drug) $1,149
  • SKYRIZI (Biological) $935.63
  • ENTYVIO (Biological) $890.42
  • HUMIRA (Biological) $786.67
  • DUPIXENT (Biological) $752.36
  • Entyvio (Biological) $708.19
  • Mavyret (Drug) $690.15
  • Epclusa (Drug) $679.17
  • MAVYRET (Drug) $635.62
  • ZENPEP (Drug) $516.76
  • LINZESS (Drug) $466.44
  • OCALIVA (Drug) $433.18
  • REMICADE (Biological) $315.54
  • Trulance (Drug) $300.15
  • TREMFYA (Drug) $294.42
  • MOVIPREP (Drug) $290.55

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Southfield